Hjem › Bronkiekræft › Illinois
Bronkiekræft kliniske forsøg i Illinois
5 studier for Bronkiekræft søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
- Springfield Clinic Main Campus, Springfield
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Illinois Cancer Specialists, Arlington Heights
- University of Illinois Hospital and Health Sciences Systems, Chicago
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07185997Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Advocate Aurora Health, Park Ridge
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 26. jun. 2026 · NCT04614103A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- University of Chicago, Chicago
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03093116Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Edward Hines Jr. VA Hospital, Hines, IL, Hines
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 19. feb. 2026 · NCT02984761Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.